C12Y 101/01023
Histidinol dehydrogenase
Official title: Histidinol dehydrogenase (1.1.1.23)
C12Y101/01023 (Histidinol dehydrogenase) appears on 2 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 5
- Assignees
- 4
- Inventors
- 19
- Latest grant
- 29 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant expression vector for producing highly-expressed human serum albumin, host strain, and use of host strain16 Jul 2026US 2026/0201017 A1Hebei Huakai Huihe Biomedical Co., Ltd.
- Engineered Biosynthetic Pathways for Production of Histamine by Fermentation18 Apr 2024US 2024/0124907 A1Zymergen Inc.
- Enhanced production of histidine, purine pathway metabolites, and plasmid dna2 Mar 2023US 2023/0065419 A1Ginkgo Bioworks, Inc.
- Engineered biosynthetic pathways for production of histamine by fermentation17 Jun 2021US 2021/0180096 A1Zymergen Inc.
- Transformant which produces glycine repeat sequence protein11 Apr 2013US 2013/0090455 A1
Most cited
By later US patents